My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about MSON

High Intensity Focused Ultrasound (HIFU) now Available at New Location in

Mexico

    CANCUN, Mexico, Nov. 30 /PRNewswire/ -- A new clinic in Cancun, Mexico
 will offer treatment of localized prostate cancer with HIFU, an ultrasound
 therapy. This is the second facility in Mexico to offer this therapy; HIFU
 is also available at Hospital San Javier located in Puerto Vallarta.
 
     This month, HIFU became available at Galenia Hospital, a private,
 functional hospital with a modern, minimalist atmosphere especially
 designed for the comfort of both patients and physicians. Galenia opened in
 Cancun in March 2006 to offer services to patients at the popular travel
 destination. Adding the Cancun facility to the locations that already offer
 HIFU in Mexico, Canada, the Dominican Republic and the Bahamas allows for
 optimal flexibility for those seeking HIFU.
 
     Cancun becomes the seventh location outside of the U.S. in North and
 South America to offer HIFU for localized prostate cancer and BPH. Other
 locations include Toronto, Canada; Niagara Falls, Canada; Puerto Vallarta,
 Mexico; Buenos Aires, Argentina; Santo Domingo, Dominican Republic and San
 Jose, Costa Rica.
 
     The Sonablate(R) 500, the HIFU treatment device, is not approved for
 use in the U.S. The device remains investigational in the U.S. and is being
 studied for the treatment of prostate cancer in clinical trials in the U.S.
 The U.S. Food and Drug Administration has made no decision as to the safety
 or efficacy of the Sonablate(R) 500 for the treatment of prostate cancer.
 
     The Sonablate(R) 500 is intended for use by licensed practitioners. You
 should consult your doctor for further information about HIFU with the
 Sonablate(R) 500. For more information about HIFU in Cancun or any other
 International HIFU Centers in Canada, the Caribbean, and Latin America,
 visit http://www.InternationalHIFU.com.
 
     The Sonablate(R) 500 is developed and owned by Focus Surgery, Inc. and
 manufactured under contract by Misonix, Inc. (Nasdaq:   MSON) which also
 holds distribution rights in Europe. Takai Hospital Supply Ltd. and THS
 International distribute the Sonablate(R) 500 in Southeast Asia and the
 Middle East.
 
 
 

SOURCE Therapeutic Ultrasound Management